Cingulate (CINGW) Selling, General & Administrative (2021 - 2026)
Powered by 
Analysis
Cingulate (CINGW) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.84 Bn | 623.08 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 441.33 Bn | 434.76 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 364.84 Bn | 357.70 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 266.34 Bn | 258.65 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Pfizer | 159.07 Bn | 147.37 Bn | 10.94 Bn | 3.41 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | -2.87 Bn |
| 7 | Revolution Medicines | 44.22 Bn | 44.22 Bn | - | 110.21 Mn |
| 8 | Incyte | 25.24 Bn | 20.70 Bn | 1.57 Bn | 351.74 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.76 Bn | 683.80 Mn | 206.70 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 3.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 9.49 Mn |
| Jun 30, 2021 | 629,032.00 |